Dersimelagon

N/A

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameDersimelagon
Drug Alias NameMT-7117MT-7117-MB
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanocortin receptor 1 agonists
TargetsMelanocortin receptor 1
Therapy Area/IndicationsX-linked ProtoporphyriaPorphyriasScleroderma, Diffuse +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[17
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMitsubishi Tanabe Pharma
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsX-linked ProtoporphyriaPorphyriasScleroderma, Diffuse +[6
Inactive IndicationsHepatic Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A